Entropy Technologies LP Purchases New Position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Key Points

• Entropy Technologies LP acquired a new position in Sabra Healthcare REIT by purchasing 25,940 shares valued at approximately $453,000 during the 1st quarter.
• Sabra Healthcare REIT reported earnings of $0.38 EPS for the latest quarter, exceeding analyst estimates of $0.36, with a net margin of 24.87% and revenue of $189.15 million.
• The company announced a quarterly dividend of $0.30 per share, which represents an annualized dividend yield of 6.5%.

Entropy Technologies LP purchased a new stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The fund purchased 25,940 shares of the real estate investment trust's stock, valued at approximately $453,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in SBRA. UMB Bank n.a. grew its holdings in shares of Sabra Healthcare REIT by 379.6% during the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock valued at $36,000 after purchasing an additional 1,621 shares during the last quarter. Assetmark Inc. grew its holdings in shares of Sabra Healthcare REIT by 37.8% during the 1st quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock valued at $63,000 after purchasing an additional 989 shares during the last quarter. Fifth Third Bancorp grew its holdings in shares of Sabra Healthcare REIT by 110.3% during the 1st quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock valued at $67,000 after purchasing an additional 2,011 shares during the last quarter. GF Fund Management CO. LTD. bought a new stake in shares of Sabra Healthcare REIT during the 4th quarter valued at approximately $74,000. Finally, Harbor Capital Advisors Inc. grew its holdings in Sabra Healthcare REIT by 17.2% during the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock worth $76,000 after acquiring an additional 642 shares during the last quarter. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT Trading Down 0.5%

NASDAQ:SBRA opened at $18.53 on Thursday. The firm's fifty day moving average is $18.31 and its 200-day moving average is $17.59. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. Sabra Healthcare REIT, Inc. has a 52 week low of $15.60 and a 52 week high of $20.03. The firm has a market cap of $4.44 billion, a P/E ratio of 24.38, a P/E/G ratio of 1.54 and a beta of 0.86.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. During the same period in the prior year, the firm posted $0.36 EPS. The company's quarterly revenue was up 7.4% on a year-over-year basis. Equities analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Friday, August 15th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.5%. The ex-dividend date of this dividend is Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio is currently 157.89%.

Insider Activity at Sabra Healthcare REIT

In other news, Director Michael J. Foster sold 11,000 shares of the company's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the sale, the director directly owned 64,725 shares of the company's stock, valued at approximately $1,179,289.50. This represents a 14.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 1.20% of the company's stock.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Scotiabank upped their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. JMP Securities upped their price target on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research report on Wednesday, August 6th. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $20.00.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.